Therapy development for epilepsy and rare diseases

What we do

We are a boutique consultancy specialized in therapy development for epilepsy and rare neurodevelopmental disorders. Our team has been working on developmental and epileptic encephalopathies (DEEs) since before the term was coined, giving us unique perspective on how the field has evolved.

Within this niche, we support biopharma across the full value chain, from strategy to preclinical, clinical, regulatory, and communications. Over two decades, we have built a trusted network that helps our clients open doors, anticipate stakeholder needs, and build credibility in a complex ecosystem.

From seed-stage biotech to global pharma, we help teams make critical decisions at every stage of therapy development. Discover our services below.

Pipeline and portfolio strategy

Clinical and regulatory development support

Medical Affairs, communications and patient engagement

 

Featured publications

2025 Trends in Molecular Medicine

Gene therapies for neurogenetic disorders

see all publications…

Recent insights

see all insights…

Why work with us

Clients choose Dracaena Consulting because we bring:

Over 20 years of experience in research and drug development in the areas of neurodevelopment and epilepsy.

Unique cross-disciplinary expertise bridging science, strategy, and patient perspectives.

Global network of experts and advocates for scalable insights.

Track record and proven impact: from shaping early development strategy to informing licensing and investment decisions.